Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now early-phase tilt

Congestive Heart Failure: early-phase trial registry

8 of 52 indexed Congestive Heart Failure trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #271 of 28,707 conditions by registered trial count.

52 US clinical trials · 8 currently recruiting · #271 of 28,707 conditions by registered trial count

Congestive Heart Failure: 52 US clinical trials tracked, 8 recruiting.

Congestive Heart Failure is the subject of 52 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 3 of these trials.

Enrollment posture brief

Registry condition congestive-heart-failure

OPEN 8 | RECR 15% | LATE 3 | EARLY 9 | RANK #271 | SPON 3

Nearest open-share peer: Arthroplasty, Replacement, Knee (15% recruiting · 13 trials)

Pediatric Cancer59.6%Hidradenitis Suppurativa54.7%Idiopathic Pulmonary Fibrosi42.3%Depressive Disorder, Major26.4%Congestive Heart Failure (th…15%
Open-enrollment share among volume-matched conditions near Congestive Heart Failure

Congestive Heart Failure lists 8 open slots (15% of 52 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Congestive Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Congestive Heart Failure is recruiting below its size-band peers.

    8 of 52 indexed trials (15.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Congestive Heart Failure trials is spread across many organizations.

    Abbott Medical Devices accounts for 3 of 52 trials (5.8%). 40 distinct sponsors appear on at least one study for this condition label.

  3. Typical Congestive Heart Failure enrolment sits around 139 participants.

    Median target enrolment is 139 among the 52 trials that report a genuine target (sentinel values excluded). 23 of those (44.2%) plan for fewer than 100 participants.

  4. Congestive Heart Failure research is mostly interventional.

    41 interventional and 11 observational studies make up this index (78.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 14Phase 25Phase 33

Open and recent trials

52 total, page 1 of 2

RECRUITING NA 798 participants

Care Transitions App for Patients With Multiple Chronic Conditions

Brigham and Women's Hospital

NCT06051058

RECRUITING 550 participants

Circulating Markers for Ischemic Heart Disease

UConn Health

NCT00762333

RECRUITING NA 388 participants

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

University of Tennessee

NCT06374277

RECRUITING 300 participants

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

University of Utah

NCT01099982

RECRUITING 200 participants

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

Mayo Clinic

NCT05507879

RECRUITING NA 112 participants

Stress and Congestive Heart Failure

Yale University

NCT04551560

RECRUITING Phase 1 57 participants

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Sardocor

NCT04703842

RECRUITING 20 participants

Palliative Care for People With HF

Indiana University

NCT07356843

ACTIVE NOT RECRUITING NA 1,686 participants

SyncAV Post-Market Trial

Abbott Medical Devices

NCT04100148

ACTIVE NOT RECRUITING NA 1,080 participants

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

University of California, Los Angeles

NCT06526884

ACTIVE NOT RECRUITING 400 participants

Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study

Massachusetts General Hospital

NCT02632656

ACTIVE NOT RECRUITING 302 participants

Prediction of ARrhythmic Events With Positron Emission Tomography II

State University of New York at Buffalo

NCT03493516

ACTIVE NOT RECRUITING Phase 2 150 participants

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

AskBio

NCT05598333

ACTIVE NOT RECRUITING Phase 1 17 participants

AB-1002 in Patients With Class III Heart Failure

AskBio

NCT04179643

COMPLETED NA 1,915 participants

Improving Patient Prioritization During Hospital-homecare Transition

Columbia University

NCT04136951

COMPLETED NA 1,820 participants

MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy

Boston Scientific Corporation

NCT00180271

COMPLETED NA 1,660 participants

Tele-HF: Yale Heart Failure Telemonitoring Study

Yale University

NCT00303212

COMPLETED 1,214 participants

CardioMEMS HF System Post Approval Study

Abbott Medical Devices

NCT02279888

COMPLETED 450 participants

PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy

Medtronic Cardiac Rhythm and Heart Failure

NCT00253357

COMPLETED Phase 2 360 participants

Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF

Boston Scientific Corporation

NCT00158951

COMPLETED NA 316 participants

Aetna_Intel Medicare Home Biomonitoring Study

Aetna

NCT01105572

COMPLETED Phase 2 305 participants

At-Home Automated External Defibrillator (AED) Training Study

Public Health - Seattle and King County

NCT00219674

COMPLETED Phase 1 290 participants

Empowering Elders Through Technology

Robert Wood Johnson Foundation

NCT00261664

COMPLETED NA 287 participants

Evaluating a Low-Literacy Discharge Medication Education Tool

University of California, Los Angeles

NCT00408733

COMPLETED NA 251 participants

Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral

Johns Hopkins University

NCT05574699

COMPLETED Phase 2 204 participants

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Takeda

NCT00050076

COMPLETED NA 200 participants

Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?

Jewish Hospital, Cincinnati, Ohio

NCT01878968

COMPLETED NA 195 participants

Insomnia Self-Management in Heart Failure

Yale University

NCT02660385

COMPLETED Phase 3 150 participants

DILIPO (DILutIonal HyPOnatremia)

Sanofi

NCT00274326

COMPLETED NA 139 participants

Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA

Peter Lindenauer, MD

NCT05562037

COMPLETED NA 124 participants

Health Literacy in Patients With Congestive Heart Failure

Griffin Hospital

NCT00508716

COMPLETED NA 105 participants

Leveraging Home Health Aides to Improve Outcomes in Heart Failure

Weill Medical College of Cornell University

NCT04239911

COMPLETED NA 97 participants

Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions

Treatment Research Institute

NCT02059005

COMPLETED Phase 3 75 participants

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

Shaddy, Robert, M.D.

NCT00129363

COMPLETED NA 66 participants

Congestive Heart Failure Weight Study

Central DuPage Hospital

NCT01185249

COMPLETED NA 60 participants

Mind-body Interventions in Cardiac Patients

Massachusetts General Hospital

NCT01270568

COMPLETED 52 participants

Utility of Serial BNP Levels in Emergency Department CHF

Ohio State University

NCT00534066

COMPLETED Phase 2 50 participants

Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes

National Heart, Lung, and Blood Institute (NHLBI)

NCT00064727

COMPLETED 47 participants

Evaluation of the EasySense System in Congestive Heart Failure

Ohio State University

NCT03237923

COMPLETED NA 43 participants

Heart Failure Patient Self-Management Web Portal Pilot Study

University of Michigan

NCT01009151

COMPLETED 42 participants

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Northwestern University

NCT04362553

COMPLETED NA 41 participants

His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy

University of Chicago

NCT02700425

COMPLETED Phase 1 33 participants

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)

University of Louisville

NCT00474461

COMPLETED NA 31 participants

Daxor - Blood Volume Analysis

Duke University

NCT04111185

COMPLETED Phase 3 30 participants

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial

Mayo Clinic

NCT02885636

COMPLETED NA 30 participants

Study of Coronary Artery Disease by Two Types of Angiography

VA Connecticut Healthcare System

NCT00273819

COMPLETED NA 30 participants

Researching Emotions And Cardiac Health

Massachusetts General Hospital

NCT02737761

COMPLETED NA 18 participants

Hemodynamic Effects of Spironolactone in Patients With Heart Failure

University of Toledo Health Science Campus

NCT00860340

COMPLETED NA 16 participants

EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant

Abbott Medical Devices

NCT01615835

COMPLETED NA 13 participants

Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring

University of Pennsylvania

NCT03234088

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 5
Phase 3 3

Named interventions

Most-linked intervention names on Congestive Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
MCC-135 Drug
1 trials
Social Risk Score and CDS Tool Other
1 trials
Cardiac resynchronization therapy with defibrillation Device
1 trials
Self-Management Education for Heart Failure Behavioral
1 trials
PREVENT clinical decision support Other
1 trials
EnSite NavX System Other
1 trials
Medication Education Tool Other
1 trials

US sites by state

Facility locations filed on Congestive Heart Failure trials. A trial with sites in several states counts in each.

California 10 trials
New York 7 trials
Massachusetts 7 trials
Illinois 7 trials
Florida 7 trials
Pennsylvania 6 trials
Ohio 6 trials
Georgia 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Congestive Heart Failure page

52 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Congestive Heart Failure condition card totals 52 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.